Skip to Main Content

Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

And here is our regular feature in which we highlight a different person each week. This time around, we note that Enzyvant hired Rachelle Jacques as chief executive officer. Most recently, she worked at Alexion Pharmaceuticals (ALXN), where she was senior vice president and global franchise head of complement.


Fate Therapeutics (FATE) hired Dr. Sarah Cooley as senior vice president, clinical translation;

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!